JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (7): 88-90.doi: 10.6040/j.issn.1671-7554.0.2015.730

Previous Articles     Next Articles

Clinical effect of milrinone atomization inhalation on treating severe pneumonia complicated with heart failure of neonates and infants

XU Tianyi1, WU Ping1, WANG Ailing1, CHEN Liping2   

  1. 1. Department of Pediatrics, The Fourth Peoples Hospital of Jinan City, Jinan 250031, Shandong, China;
    2. Department of Pediatrics, Taian City Central Hospital, Taian 271000, Shandong, China
  • Received:2015-08-04 Online:2016-07-10 Published:2016-07-10

Abstract: Objective To discuss the curative effect and security of milrinone atomization inhalation on treating severe pneumonia complicated with heart failure in noenates and infants. Methods A total of 240 cases with severe pneumonia complicated with heart failure in the fourth Peoples Hospital of Jinan City from 2012 to 2015 were randomly divided into control group and observation group, 120 in each group. The control group was treated with digitalis, diuretic, and other conventional therapies; on this basis, the observation group was treated additionally with milrinone atomization inhalation. Changes of the clinical efficacy and cardiac function indexes of the two groups were observed. Results After 5 days of treatment, clinical symptoms, signs and cardiac function indexes were improved significantly in the two groups. The improvement of cardiac function indexes in the observation group was better than that in the control group. The difference of clinical efficacy and cardiac function indexes before and after the treatment in the two groups were statistically significant(P<0.05). Conclusion On the basis of routine treatment such as digitalis and diuretic therapy, milrinone atomization inhalation can reduce the pulmonary circulation resistance, cardiac preload and afterload, thus effectively improve the heart function in noenates and infants with severe pneumonia complicated with heart failure.

Key words: Severe pneumonia, Pulmonary artery hypertension, Milrinone atomization, Heart failure

CLC Number: 

  • R725.6
[1] 马登勋,王利东.米力农联合多巴胺治疗小儿肺炎合并心力衰竭[J]. 新乡医学院学报, 2012, 29(5):381-383. MA Dengxun, WANG Lidong. Milrinone combined with dopamine in the treatment in children with pneumonia complicated with heart failure[J]. Xinxiang Medical College Journal, 2012, 29(5):381-383.
[2] Kobayashi S, Susa T, Tanaka T, et al. Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure[J]. Circ J, 2012, 76(7):1646-1653.
[3] 胡亚美, 江载芳.诸福棠实用儿科学[M]. 7 版. 北京: 人民卫生出版社, 2002: 1511-1525.
[4] Hentschel T, Yin N, Riad A, eI al. Inhalation of the phosphodies-terase-3 inhibitor milrinone attenuates pulmonary hypertension in an experimental model of congestive heart failure[J]. Anesthesiology, 2007, 106(1):124-131.
[5] 王耀菊. 米力农治疗小儿充血性心力衰竭疗效观察[J]. 中国实用儿科杂志, 2010, 22(11): 91-92. WANG Yaoju. Milrinone in the treatment of children with congestive heart failure curative effect observation[J]. Chinese Journal of Practical Pediatrics, 2010, 22(11):91-92.
[6] 孔令先. 米力农治疗顽固性心力衰竭的临床疗效及安全性分析[J]. 中国保健营养, 2013, 6(1):201-202. KONG Lingxian. Milrinone in treatment of refractory heart failure clinical efficacy and safety analysis[J]. China Health Nutrition, 2013, 6(1):201-202.
[7] Rieg AD, Suleiman S, Perez-Bouza A, et al. Milrinone relaxes plumonary veins in guinea pigs and humans[J]. PLoS One, 2014, 9(1):e876-885. doi: 10.1371/journal.pone.0087685.
[8] 冯永萌, 郭瑞霞, 张菲菲. 不同剂量米力农在充血性心力衰竭治疗中的疗效及安全性[J]. 中国医药指南, 2013, 11(3): 152-153. FENG Yongmeng, GUO Ruixia, ZHANG Feifei. Different dose of milrinone in the treatment of congestive heart failure efficacy and safety [J]. Guide to Chinese Medicine, 2013, 11(3):152-153.
[9] Birger A, Mikael A, Anders M, et al. Milrinone improves dias-tolic function in coronary artery bypass surgery as assessed by acoustic quantification and peak filling rate: a prospective randomized study[J]. J Cardiothorac Vasc Anesth, 2010, 24(2):244-249.
[10] Lee J, Kim GB, Kwon HW, et al. Safety and efficacy of the off-label use of milrinone in pediatric with heart desases[J] Korean Circ J, 2014, 44(5):320-327.
[11] Mc Namara PJ, Laique F, Muang-In S, et al. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn[J]. J Crit Care, 2006, 21(2):217-222.
[12] Lakshminrusimha S, Porta NF, Farrow KN, et al. Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn[J]. Pediatr Crit Care Med, 2009, 10(1):106-112.
[13] Faraday N. Perioperative platelet activation and the inhibitory effect of milrinone[J]. Anesthesiology, 2009, 111(6):1185-1186.
[14] Lamarche Y, Malo O, Thorin E, et al. Inhalde but not ineravenous milrinong prevents pulmonary endothelial dysfunction after cardiopulmonary bypass[J]. J Thorac Cardiovasc Surg, 2005, 130(1):83-92.
[1] JIANG Yunshan, TAN Hong, LI Xiaoyan, SU Li, ZHANG Guoming, ZHANG Hongming, MENG Nan. Effects of perindopril on the expression of plasma miR-423-5p and cardiac function in patients with heart failure [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 55-59.
[2] JIANG Hongmei1,2, CHEN Wenqiang1. Clinical implication of psychotherapy on elderly patients with coronary heart failure undergoing rehabilitation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 85-88.
[3] CHEN Dong-chang, GU Ying, LU Ke-feng. Changes of serum high sensitivity of troponin T concentration and its clinical significance in chronic heart failure [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(2): 69-72.
[4] LIU Shan-wen1, WANG Fu1, LI Bin2, GENG Hai-hua3, LI Cai-e4, XU Zhe5, LI Rui1, XIAO Jie1, ZHANG Sen1, JI Xiao-ping1. Isolation of rat bone marrow mesenchymal stem cell-derived exosome and the uptake of exosome by H9C2 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 1-7.
[5] GU Ying, WANG Ai-hong, QU Fu-chao, CHEN Dong-chang, ZHANG Ke, LU Ke-feng. Role of Heme oxygenase-1 on the apoptosis of myocardial cells induced by angiotensin Ⅱ [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(06): 1-4.
[6] SONG Jie-jie, LIU Lin, LI Li. Short-term heart rate variability to assess cardiac status of heart failure patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 97-.
[7] XIA Long1, MIAO Wei2, WANG Li-qi2, ZHU Shi-ming2. Research of plasma Apelin level in hypertensive patients with heart failure [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(1): 75-.
[8] WU Chunjian, XU Yongqing. Serum resistin, MMP2 and NT-ProBNP levels in patients with congestive heart failure [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(7): 87-90.
[9] LI Na, BIAN Hongjun, ZHANG Juan, JI Xiaoping. Detection and significance of Th17 and Treg cells in patients with chronic heart failure [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(6): 100-103.
[10] CAI Wei-dong, LI Xiaolu, BI Yan-ping . Effectiveness and safety of recombinant human brain natriuretic peptide in aged patients with acute myocardial infarction complicated with heart failure [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(10): 92-94.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!